Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Paclitaxel-eluting Type, Others); End-Users (Hospitals, Clinics, Others) and Geography

Report Code: TIPRE00021671 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

A drug-eluting balloon (DEB) Catheter is a conventional semi-compliant percutaneous transluminal coronary angioplasty (PTCA) balloon catheter. It is covered with an anti-restenotic drug released during inflation of the balloon into the vessel wall. It prevents re-narrowing of the coronary arteries. It yields short-term, homogenous, fast, local drug delivery. It promotes enhanced vessel healing and helps in reducing the need for prolonged dual antiplatelet therapy. Drug-eluting balloons (DEB) catheters are a potential alternative to combat restenosis.

MARKET DYNAMICS

The increase in geriatric population, rise in cardiovascular disease, and changes in the lifestyle of individuals lead to obesity, hypertension, and other factors that result in vascular disease are supposed to drive percutaneous transluminal coronary angioplasty drug-eluting balloon catheters market growth. Furthermore, rising technological advancements and reclassification of catheters in FDA policy will propel the development of the market during the forecast period. The rising demand for minimally invasive surgeries, improved healthcare facilities in developing economies, and rise in disposable incomes are expected to surge the market growth. However, the availability of alternative therapies may restrain the market growth.

MARKET SCOPE

The "Percutaneous Transluminal Coronary Angioplasty Drug-Eluting Balloon Catheters Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of percutaneous transluminal coronary angioplasty drug-eluting balloon catheters market with detailed market segmentation by type and end-users. The percutaneous transluminal coronary angioplasty drug-eluting balloon catheters market are expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in percutaneous transluminal coronary angioplasty drug-eluting balloon catheters market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The percutaneous transluminal coronary angioplasty drug-eluting balloon catheters market are segmented on the basis of type and end-users. On the basis of type, the market is segmented into paclitaxel-eluting type, and others. On the basis of end-users, the market is segmented as hospitals, clinics, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the percutaneous transluminal coronary angioplasty drug-eluting balloon catheters market based on various segments. It also provides market size and forecast estimates from year 2018 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The percutaneous transluminal coronary angioplasty drug-eluting balloon catheters market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting percutaneous transluminal coronary angioplasty drug-eluting balloon catheters market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the percutaneous transluminal coronary angioplasty drug-eluting balloon catheters market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the percutaneous transluminal coronary angioplasty drug-eluting balloon catheters market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from percutaneous transluminal coronary angioplasty drug-eluting balloon catheters market are anticipated to have lucrative growth opportunities in the future with the rising demand for percutaneous transluminal coronary angioplasty drug-eluting balloon catheters in the global market. Below mentioned is the list of few companies engaged in the percutaneous transluminal coronary angioplasty drug-eluting balloon catheters market.

The report also includes the profiles of key players in percutaneous transluminal coronary angioplasty drug-eluting balloon catheters market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  B. Braun Melsungen AG
  •  Medtronic PLC
  •  Abbott Inc.
  •  Boston Scientific Corporation
  •  Biotronik Se & Co.KG
  •  Spectranetics Corporation
  •  Cordis Corporation
  •  ENDOCOR GmbH
  •  CR Bard Inc
  •  Terumo Corporation

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market - By Type
1.3.2 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market - By End-Users
1.3.3 Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON CATHETERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON CATHETERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON CATHETERS MARKET - GLOBAL MARKET ANALYSIS
6.1. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON CATHETERS - GLOBAL MARKET OVERVIEW
6.2. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON CATHETERS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON CATHETERS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PACLITAXEL-ELUTING TYPE
7.3.1. Overview
7.3.2. Paclitaxel-eluting Type Market Forecast and Analysis
7.4. OTHERS
7.4.1. Overview
7.4.2. Others Market Forecast and Analysis
8. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON CATHETERS MARKET - REVENUE AND FORECASTS TO 2028 - END-USERS
8.1. OVERVIEW
8.2. END-USERS MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis

9. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON CATHETERS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Overview
9.1.2 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis
9.1.3 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By Type
9.1.4 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By End-Users
9.1.5 North America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.1.5.1.1 Canada Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.1.5.1.2 Canada Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.1.5.2 Mexico Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.1.5.2.1 Mexico Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.1.5.2.2 Mexico Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.1.5.3 US Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.1.5.3.1 US Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.1.5.3.2 US Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.2. EUROPE
9.2.1 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Overview
9.2.2 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis
9.2.3 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By Type
9.2.4 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By End-Users
9.2.5 Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.2.5.1.1 Germany Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.2.5.1.2 Germany Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.2.5.2 France Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.2.5.2.1 France Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.2.5.2.2 France Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.2.5.3 Italy Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.2.5.3.1 Italy Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.2.5.3.2 Italy Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.2.5.4 Spain Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.2.5.4.1 Spain Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.2.5.4.2 Spain Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.2.5.5 United Kingdom Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.2.5.5.1 United Kingdom Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.2.5.5.2 United Kingdom Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.2.5.6 Rest of Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.2.5.6.1 Rest of Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.2.5.6.2 Rest of Europe Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Overview
9.3.2 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis
9.3.3 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By End-Users
9.3.5 Asia-Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.3.5.1.1 Australia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.3.5.1.2 Australia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.3.5.2 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.3.5.2.1 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.3.5.2.2 China Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.3.5.3 India Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.3.5.3.1 India Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.3.5.3.2 India Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.3.5.4 Japan Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.3.5.4.1 Japan Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.3.5.4.2 Japan Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.3.5.5 South Korea Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.3.5.5.1 South Korea Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.3.5.5.2 South Korea Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.3.5.6 Rest of Asia-Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.3.5.6.1 Rest of Asia-Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.3.5.6.2 Rest of Asia-Pacific Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Overview
9.4.2 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis
9.4.3 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By End-Users
9.4.5 Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.4.5.1.1 South Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.4.5.1.2 South Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.4.5.2 Saudi Arabia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.4.5.2.1 Saudi Arabia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.4.5.2.2 Saudi Arabia Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.4.5.3 U.A.E Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.4.5.3.1 U.A.E Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.4.5.3.2 U.A.E Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.4.5.4 Rest of Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.4.5.4.1 Rest of Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.4.5.4.2 Rest of Middle East and Africa Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Overview
9.5.2 South and Central America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis
9.5.3 South and Central America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By Type
9.5.4 South and Central America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By End-Users
9.5.5 South and Central America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.5.5.1.1 Brazil Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.5.5.1.2 Brazil Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.5.5.2 Argentina Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.5.5.2.1 Argentina Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.5.5.2.2 Argentina Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users
9.5.5.3 Rest of South and Central America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market
9.5.5.3.1 Rest of South and Central America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by Type
9.5.5.3.2 Rest of South and Central America Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon Catheters Market by End-Users

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY DRUG ELUTING BALLOON CATHETERS MARKET, KEY COMPANY PROFILES
11.1. B. BRAUN MELSUNGEN AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. MEDTRONIC PLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ABBOTT INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BOSTON SCIENTIFIC CORPORATION
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BIOTRONIK SE AND CO.KG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. SPECTRANETICS CORPORATION
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. CORDIS CORPORATION
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ENDOCOR GMBH
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. CR BARD INC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TERUMO CORPORATION
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. B. Braun Melsungen AG
2. Medtronic PLC
3. Abbott Inc.
4. Boston Scientific Corporation
5. Biotronik Se and Co.KG
6. Spectranetics Corporation
7. Cordis Corporation
8. ENDOCOR GmbH
9. CR Bard Inc
10. Terumo Corporation
TIPRE00021671
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking